National HealthCare Corporation (NHC)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • AMEX
Market Cap: $3.26B
Last updated: Nov 17, 2026 at 11:05 AM ET
National HealthCare Corporation (NHC) Financials: Revenue, Profit and Cash Flow
National HealthCare reported revenue of $1.52B for the fiscal year ended Dec 31, 2025, up 16.1% from the year before. That year, net income was $122.61M with a net margin of 8.1%, operating cash flow was $185.08M and free cash flow was $148.63M. The quarter ended Sep 30, 2026 had revenue of $407.97M and net income of $14.18M.
Revenue and Margins
The operating margin was 8.5% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $923.58M, a compound annual rate of 5.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.52B | +16.1% | 39.3% | 8.5% | 8.1% |
| Dec 2024 | $1.31B | +14.5% | 38.0% | 6.9% | 7.8% |
| Dec 2023 | $1.14B | +5.1% | 37.6% | 5.0% | 5.7% |
| Dec 2022 | $1.09B | +1.1% | 36.8% | 2.9% | 1.8% |
| Dec 2021 | $1.07B | +4.5% | 38.0% | 4.7% | 12.9% |
| Dec 2020 | $1.03B | +3.2% | 39.6% | 4.7% | 4.1% |
| Dec 2019 | $996.38M | +1.6% | 40.5% | 4.9% | 6.8% |
| Dec 2018 | $980.35M | +1.7% | 40.6% | 5.7% | 6.0% |
| Dec 2017 | $963.89M | +4.4% | 40.7% | 5.6% | 5.8% |
| Dec 2016 | $923.58M | N/A | 40.7% | 6.6% | 5.5% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 20.1% from the year before. In the quarter ended Sep 2026, net income fell 65.4% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.52B | $1.31B | $1.14B | $1.09B | $1.07B | $1.03B | $996.38M | $980.35M | $963.89M | $923.58M |
| Cost of revenue | $921.08M | $810.93M | $712.34M | $686.17M | $666.06M | $620.99M | $592.83M | $582.72M | $572.04M | $548.01M |
| Gross profit | $596.70M | $496.45M | $429.20M | $399.57M | $408.24M | $407.23M | $403.55M | $397.63M | $391.85M | $375.57M |
| Operating income | $128.35M | $89.89M | $57.46M | $31.90M | $50.92M | $48.16M | $49.04M | $56.08M | $54.11M | $60.54M |
| Net income | $122.61M | $102.09M | $65.29M | $19.98M | $139.09M | $41.99M | $67.98M | $58.70M | $55.68M | $50.54M |
| EBITDA | $191.38M | $151.57M | $116.15M | $83.53M | $109.37M | $116.70M | $128.46M | $116.78M | $117.20M | $119.23M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $407.97M | $408.02M | $381.82M | $386.51M | $382.66M | $374.91M | $373.70M | $369.35M | $340.20M | $300.66M | $297.18M | $300.91M |
| Gross profit | $156.03M | $166.12M | $146.75M | $153.27M | $149.49M | $148.38M | $145.57M | $135.03M | $126.80M | $120.58M | $114.04M | $114.35M |
| Operating income | $40.63M | $48.94M | $32.25M | $33.12M | $30.38M | $34.09M | $30.77M | $28.91M | $22.79M | $22.52M | $15.68M | $20.44M |
| Net income | $14.18M | $40.54M | $36.10M | $25.19M | $41.01M | $24.11M | $32.29M | $6.03M | $42.70M | $27.11M | $26.25M | $27.96M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $40.00M by $52.83M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.53B | $1.52B | $1.31B | $1.28B | $1.40B | $1.36B | $1.29B | $1.08B | $1.10B | $1.09B |
| Current assets | $461.82M | $424.41M | $406.24M | $353.93M | $426.64M | $456.75M | $341.05M | $322.01M | $329.31M | $290.86M |
| Cash and equivalents | $92.83M | $76.12M | $107.08M | $58.67M | $107.61M | $147.09M | $50.33M | $43.25M | $59.12M | $26.34M |
| Total liabilities | $451.90M | $541.27M | $400.32M | $397.94M | $494.94M | $563.87M | $507.58M | $346.49M | $393.09M | $417.84M |
| Short-term debt | $7.50M | $7.50M | $860.00K | $4.99M | $32.27M | $4.42M | $14.17M | $3.92M | $3.70M | $3.48M |
| Long-term debt | $32.50M | $129.50M | $0 | N/A | N/A | N/A | $0 | $55.00M | $100.00M | $120.00M |
| Shareholder equity | $1.07B | $980.16M | $908.75M | $874.28M | $903.00M | $795.18M | $778.59M | $733.28M | $702.74M | $669.61M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.07B | $1.54B | $1.52B | $1.53B | $1.57B | $1.56B | $1.55B | $1.52B | $1.56B | $1.34B | $1.32B | $1.31B |
| Total liabilities | $936.98M | $408.87M | $427.48M | $451.90M | $513.91M | $536.84M | $540.84M | $541.27M | $575.91M | $391.85M | $393.13M | $400.32M |
| Cash and equivalents | $66.80M | $39.21M | $85.53M | $110.95M | $130.63M | $110.99M | $90.39M | $76.12M | $84.81M | $136.21M | $93.98M | $107.08M |
| Shareholder equity | $1.12B | $1.12B | $1.09B | $1.07B | $1.05B | $1.02B | $1.00B | $980.16M | $983.47M | $945.82M | $924.75M | $908.75M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 80.3% of operating cash flow. Dividends and share repurchases together came to 35.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $185.08M | $107.30M | $111.22M | $8.74M | $62.39M | $203.26M | $100.10M | $98.44M | $94.47M | $90.88M |
| Capital expenditures | $36.45M | $27.60M | $27.90M | $30.20M | $39.40M | $21.87M | $26.40M | $29.77M | $32.35M | $62.60M |
| Free cash flow | $148.63M | $79.70M | $83.31M | -$21.46M | $23.00M | $181.39M | $73.70M | $68.66M | $62.12M | $28.28M |
| Dividends paid | $38.55M | $35.85M | $35.56M | $34.35M | $32.99M | $29.43M | $31.68M | $29.83M | $28.24M | $25.80M |
| Share repurchases | $14.73M | $13.50M | $2.48M | $9.90M | $836.00K | $53.00K | $872.00K | $867.00K | $0 | $8.20M |
| Investing cash flow | -$33.86M | -$236.69M | -$17.57M | -$5.98M | -$65.89M | -$63.88M | -$14.27M | -$33.66M | -$9.56M | -$81.48M |
| Financing cash flow | -$135.96M | $100.34M | -$42.55M | -$47.64M | -$35.26M | -$41.89M | -$79.75M | -$77.27M | -$49.07M | -$27.13M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $99.15M | $43.27M | $62.53M | $16.81M | $66.20M | $62.82M | $39.26M | $12.79M | $34.21M | $50.66M | $9.65M | $25.73M |
| Capital expenditures | $577.83M | $12.53M | $9.64M | $10.40M | $9.71M | $10.20M | $6.14M | $8.16M | $5.66M | $7.83M | $5.96M | $8.60M |
| Free cash flow | -$478.68M | $30.74M | $52.89M | $6.41M | $56.49M | $52.62M | $33.12M | $4.63M | $28.55M | $42.83M | $3.69M | $17.13M |
Frequently Asked Questions About NHC
What is National HealthCare's annual revenue?
National HealthCare reported revenue of $1.52B for the fiscal year ended Dec 31, 2025.
How fast is National HealthCare's revenue growing?
Revenue was up 16.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 11.8%.
Is National HealthCare profitable?
Yes. National HealthCare reported net income of $122.61M for the fiscal year ended Dec 31, 2025, with a net margin of 8.1%.
How much free cash flow does NHC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $185.08M minus capital expenditures of $36.45M produced free cash flow of $148.63M.
How much debt does National HealthCare have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $32.50M, short-term debt of $7.50M and cash and equivalents of $92.83M.
NHC pages: Overview, Dividends, Earnings, Financials, Valuation, Competitors, Government Contracts